Home/Pipeline
Pipeline

Development and commercialization pipeline

Authorized products, ongoing trials, combination-drug proof of concept and future indications.

Development overview

Prescription digital therapeutics

Development and commercialization of condition-specific treatment software

4 programs
Product · indication
ConceptDevelopmentClinical trialAuthorizationCommercial
Korea

SleepQ®

Commercial · Nationwide prescribing

Chronic insomnia

MFDS authorization · Insurance listing
Commercial · Nationwide prescribing
Current stage · Commercial5 / 5
  1. Concept
  2. Development
  3. Clinical trial
  4. Authorization
  5. Commercial
Korea

SerenQ®

MFDS authorized

Eating disorders

NET certification
MFDS authorized
Current stage · Authorization4 / 5
  1. Concept
  2. Development
  3. Clinical trial
  4. Authorization
  5. Commercial
Germany

SleepQ® · Germany

Patient follow-up complete; analysis underway

Chronic insomnia

Charité WELT-REST · Preparing for DiGA
Patient follow-up complete; analysis underway
Current stage · Clinical trial3 / 5
  1. Concept
  2. Development
  3. Clinical trial
  4. Authorization
  5. Commercial
Korea

Migraine DTx

Technology development

Migraine

Acquired IP and DrugOS™
Technology development
Current stage · Development2 / 5
  1. Concept
  2. Development
  3. Clinical trial
  4. Authorization
  5. Commercial

Swipe horizontally to explore development stages.

Development overview

Digital combination drugs

Medication-specific treatment and patient-support development

5 programs
Product · indication
Discussion / PoC prepPoCClinical developmentAuthorizationCommercial
Korea

WELT-IP

PoC ongoing

Idiopathic pulmonary fibrosis

Joint development with Ildong
PoC ongoing
Current stage · PoC2 / 5
  1. Discussion / PoC prep
  2. PoC
  3. Clinical development
  4. Authorization
  5. Commercial
Korea

WELT-MN

PoC ongoing

Migraine

PoC ongoing
Current stage · PoC2 / 5
  1. Discussion / PoC prep
  2. PoC
  3. Clinical development
  4. Authorization
  5. Commercial
International

WELT-UA

Urology

Current stage · PoC2 / 5
  1. Discussion / PoC prep
  2. PoC
  3. Clinical development
  4. Authorization
  5. Commercial
Korea

WELT-IS

PoC preparation

Insomnia · Sleep-medication support

Handok · Medication-linked sleep support
PoC preparation
Current stage · Discussion / PoC prep1 / 5
  1. Discussion / PoC prep
  2. PoC
  3. Clinical development
  4. Authorization
  5. Commercial
United States

WELT-MN

Collaboration discussions

Migraine

Discussions on medication-linked development
Collaboration discussions
Current stage · Discussion / PoC prep1 / 5
  1. Discussion / PoC prep
  2. PoC
  3. Clinical development
  4. Authorization
  5. Commercial

Swipe horizontally to explore development stages.

Based on company information as of September 2026. Proof of concept explores feasibility and does not establish clinical efficacy.

Global development

Building on Korean commercialization experience

KR

Korea

Two MFDS authorizations; nationwide prescribing infrastructure

DE

Germany

Munich subsidiary; Charité WELT-REST follow-up complete; analysis underway; DiGA preparation

US

United States

Migraine-related patents and international research

EU

Europe

SleepQ® CE(MDR); assessment of country-specific market pathways